Showing 20 of 83 recruiting trials for “Glioblastoma”
ATM-Inhibitor WSD0628 in Combination With Radiation Therapy for Treatment of Recurrent High-Grade Glioma
RecruitingNCT06924099 ↗
TTFields General Routine Clinical Care in ndGBM Patients: a French Prospective Non-Interventional Study (TIGER France)
RecruitingNCT06041555 ↗
MRI Guided Radiotherapy and Radiobiological Data: the ISRAR Database (Irm Sequences for Radiobiological Adaptative Radiotherapy)
Hitting the Mark: Introducing State-of-the-art MRI for Precision Radiotherapy of Glioblastoma
👨⚕️ Alejandra Méndez Romero, MD, PhD, Erasmus Medical Center📍 1 site📅 Started Jan 2024View details ↗
The Efficacy and Safety of Low-dose Radiotherapy Combined With Sintilimab and Temozolomide in Recurrent Glioblastoma
Clinical Study of Oncolytic Virus in Glioblastoma
Imaging and Biological Markers for Prediction and Identification of Glioblastoma Pseudoprogression: a Prospective Study.
👨⚕️ Letterio S Politi, MD, Humanitas Research Hospital IRCCS, Rozzano-Milan📍 1 site📅 Started Nov 2023View details ↗
Tris-CAR-T Cell Therapy for Recurrent Glioblastoma
Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer
👨⚕️ Nelson Moss, MD, Memorial Sloan Kettering Cancer Center📍 1 site📅 Started Sep 2023View details ↗
Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells
👨⚕️ Benjamin Ellingson, PhD, University of California at Los Angeles📍 1 site📅 Started Sep 2023View details ↗
Crizanlizumab Alone or in Combination With Nivolumab for Glioblastoma and Melanoma With Brain Metastases
👨⚕️ Ronnie Shapira Frommer, Dr, Ronnie Shapira, MD Study Principal Investigator Ronnie.Shapira@sheba.health.gov.il📍 1 site📅 Started Jul 2023View details ↗
RMC-5552 Monotherapy in Adult Subjects With Recurrent Glioblastoma
👨⚕️ Nicholas Butowski, MD, University of California, San Francisco📍 1 site📅 Started Apr 2023View details ↗
UNIty-Based MR-Linac Guided Adaptive RadioThErapy for High GraDe Glioma-3 (UNITED-3)
131I-TLX-101 for Treatment of Newly Diagnosed Glioblastoma (IPAX-2)
CARv3-TEAM-E T Cells in Glioblastoma
Study of Liposomal Curcumin in Combination With RT and TMZ in Patients With Newly Diagnosed High-Grade Gliomas
Individualized Systems Medicine Functional Profiling for Recurrent Glioblastoma
ARISTOCRAT: Blinded Trial of Temozolomide +/- Cannabinoids
👨⚕️ Fiona Collinson, MBBS, BSc, MRCP, FRCR, PhD, University of Leeds📍 22 sites📅 Started Feb 2023View details ↗
RecruitingNCT06283927 ↗
The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
RecruitingNCT06146725 ↗
The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →